Cara Therapeutics
Frederique Menzaghi is an accomplished professional in the pharmaceutical industry with extensive experience in research and development. Currently serving as VP of Research & Development at Cara Therapeutics since July 2014, Frederique previously held the position of Chief Scientific Officer and Senior VP of Research & Development at Cara Therapeutics, Inc. Prior to this role, Frederique worked at Arena Pharmaceuticals from 1999 to 2003, where responsibilities included Research Director for In Vivo Pharmacology and various scientific roles.
This person is not in any offices
Cara Therapeutics
3 followers
Cara Therapeutics is an early commercial-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors, or KORs.